Javascript must be enabled to continue!
Synthetic measurements of runaway electron synchrotron emission in the SPARC tokamak
View through CrossRef
With plasma currents up to 8.7 MA, the SPARC tokamak runs the risk of forming multi-MA beams of relativistic “runaway” electrons (REs), which could damage plasma facing components if unmitigated. The infrared (IR) and visible imaging and visible spectroscopy systems in SPARC are designed with measurements of synchrotron emission from REs in mind. Synchrotron radiation is emitted by REs along their direction of motion, opposite the plasma current. Matched clockwise and counterclockwise wide views are proposed to detect synchrotron and background radiation, allowing observation of RE synchrotron emission in both plasma current configurations. Due to SPARC’s high toroidal magnetic field strength, 12.2 T on axis, the synchrotron light spectrum is expected to peak in the visible-IR wavelength range. The synthetic diagnostic tool, Synchrotron Orbit-Following Toolkit, is used to model synchrotron images and spectra for three scenarios, with appropriate magnetic equilibria for each: REs generated during plasma current ramp-up, steady-state flat-top (although unlikely, but serving as a reference), and disruptions. Required time resolutions, achievable spatial coverage, and appropriate spectral ranges for various RE energies are assessed.
Title: Synthetic measurements of runaway electron synchrotron emission in the SPARC tokamak
Description:
With plasma currents up to 8.
7 MA, the SPARC tokamak runs the risk of forming multi-MA beams of relativistic “runaway” electrons (REs), which could damage plasma facing components if unmitigated.
The infrared (IR) and visible imaging and visible spectroscopy systems in SPARC are designed with measurements of synchrotron emission from REs in mind.
Synchrotron radiation is emitted by REs along their direction of motion, opposite the plasma current.
Matched clockwise and counterclockwise wide views are proposed to detect synchrotron and background radiation, allowing observation of RE synchrotron emission in both plasma current configurations.
Due to SPARC’s high toroidal magnetic field strength, 12.
2 T on axis, the synchrotron light spectrum is expected to peak in the visible-IR wavelength range.
The synthetic diagnostic tool, Synchrotron Orbit-Following Toolkit, is used to model synchrotron images and spectra for three scenarios, with appropriate magnetic equilibria for each: REs generated during plasma current ramp-up, steady-state flat-top (although unlikely, but serving as a reference), and disruptions.
Required time resolutions, achievable spatial coverage, and appropriate spectral ranges for various RE energies are assessed.
Related Results
SPARC in cancer-associated fibroblasts is an independent poor prognostic factor in non-metastatic triple-negative breast cancer and exhibits pro-tumor activity
SPARC in cancer-associated fibroblasts is an independent poor prognostic factor in non-metastatic triple-negative breast cancer and exhibits pro-tumor activity
Abstract
Purpose
Triple-negative breast cancer (TNBC) is the most aggressive breast cancer subtype and lacks specific targeted ...
Correlation of SPARC, ER, PR, and HER2 tumor with progression-free survival from a phase II neoadjuvant trial of gemcitabine, epirubicin, and nab-paclitaxel
Correlation of SPARC, ER, PR, and HER2 tumor with progression-free survival from a phase II neoadjuvant trial of gemcitabine, epirubicin, and nab-paclitaxel
618 Background: Neoadjuvant combinations of gemcitabine (G), anthracyclines and taxanes have demonstrated substantial activity with pCR rates of 20–25%. Secreted protein acidic ri...
KnowMore: an automated knowledge discovery tool for the FAIR SPARC datasets
KnowMore: an automated knowledge discovery tool for the FAIR SPARC datasets
Abstract
This manuscript provides the methods and outcomes of KnowMore, the Grand Prize winning automated knowledge discovery tool developed by o...
Abstract POSTER-BIOL-1344: Epigenetic regulation of SPARC in ovarian cancer
Abstract POSTER-BIOL-1344: Epigenetic regulation of SPARC in ovarian cancer
Abstract
Background: We have previously reported the tumor suppressor effect of Secreted protein acidic and rich in cysteine (SPARC) in ovarian cancer in vitro and i...
KnowMore: an automated knowledge discovery tool for the FAIR SPARC datasets
KnowMore: an automated knowledge discovery tool for the FAIR SPARC datasets
Background:
This manuscript provides the methods and outcomes of KnowMore, the Grand Prize winning automated knowledge discovery tool developed by our team duri...
Data from Persistent Activation of the Fyn/ERK Kinase Signaling Axis Mediates Imatinib Resistance in Chronic Myelogenous Leukemia Cells through Upregulation of Intracellular SPARC
Data from Persistent Activation of the Fyn/ERK Kinase Signaling Axis Mediates Imatinib Resistance in Chronic Myelogenous Leukemia Cells through Upregulation of Intracellular SPARC
<div>Abstract<p>SPARC is an extracellular matrix protein that exerts pleiotropic effects on extracellular matrix organization, growth factor availability, cell adhesion...
Data from Persistent Activation of the Fyn/ERK Kinase Signaling Axis Mediates Imatinib Resistance in Chronic Myelogenous Leukemia Cells through Upregulation of Intracellular SPARC
Data from Persistent Activation of the Fyn/ERK Kinase Signaling Axis Mediates Imatinib Resistance in Chronic Myelogenous Leukemia Cells through Upregulation of Intracellular SPARC
<div>Abstract<p>SPARC is an extracellular matrix protein that exerts pleiotropic effects on extracellular matrix organization, growth factor availability, cell adhesion...
Abstract 1654: Cisplatin resistance is associated with autophagy in SPARC expressing medulloblastoma cells.
Abstract 1654: Cisplatin resistance is associated with autophagy in SPARC expressing medulloblastoma cells.
Abstract
Medulloblastoma is the most common malignant brain tumor in children and is associated with a poor outcome. Our previous studies indicate that SPARC express...

